This week in MedTech, funding activity highlights a clear shift toward smarter, more connected care. Companies advancing brain monitoring, neuromodulation, surgical robotics, and AI-powered diagnostics are drawing strong investor interest. As these technologies mature, they’re redefining how and where care happens – making precision medicine even more personal and accessible than ever. Details follow below.
CoMind raises $102.5M to support non-invasive brain monitoring tech
Its latest funding round was led by Plural. Existing investors Angelini Ventures, LocalGlobe, Octopus Ventures, Crane, Backed VC and Entrepreneurs First joined as well.
The company plans to use funds to advance regulatory efforts for its first product, CoMind One. It also aims to complete additional clinical trials, expand its team and enter into new manufacturing partnerships.
Founder and CEO James Dacombe
Last week’s tracker: HistoSonics, Adagio & more
Onward announces $58.1 million private placement
The private placement with institutional investors includes ordinary shares with a nominal value of €0.12 apiece. The company expects to raise gross proceeds of approximately €50 million ($58.1 million) in the placement.
The company plans to use its proceeds, along with its existing cash balance, to fund development initiatives. Those include product development, clinical studies and regulatory activities for the investigational ARC-IM system.
CEO Dave Marver
Niterra Ventures participates in oversubscribed $50M growth financing round for Cala
With this investment, Cala will scale commercial operations and expand its sales and marketing efforts to educate both patients and healthcare providers about this innovative therapy.
Its products are the only FDA-cleared, clinically validated, noninvasive devices for the relief of action hand tremors in essential tremor and Parkinson’s disease.
CEO Deanna Harshbarger
Hyperfine prices $17.5M offering
The offering includes 14 million shares of its Class A common stock priced at $1.25 per share. It is selling all shares in the offering. It offered underwriters a 30-day option to purchase up to 2.1 million shares of Class A common stock. That equals 15% of the total number of shares in the offering, at the public offering
Lake Street Capital Markets serves as sole book-runner for the offering. The company plans to use the proceeds from the offering for working capital and general corporate purposes. Those include commercial, manufacturing and R&D activities.
President and CEO Maria Sainz
Adaptyx raises $14M to support multi-analyte monitoring biowearable
The company plans to use the proceeds to support its multi-analyte molecular monitoring device. The seed round brings its total funding to $23 million since inception in 2022.
Interlagos led the round with significant participation from Overwater Ventures. Starbloom Capital, Stanford University, the Chan Zuckerberg Biohub, Hyperlink Ventures, Cantos Ventures, Humba Ventures and Seaside Ventures all participated, too.
Co-founder and CEO Vijit Sabnis
Roclub raises $11.7m to support US teleoperation platform launch
The funds will be used to fuel the US launch of its platform for the remote operation (teleoperation) of medical devices in healthcare settings where practitioner shortfalls exist.
The Series A funding round was led by Smedvig Ventures and YZR Capital, and saw participation from existing investor Speedinvest and a range of angel investors.
Co-founder André Glardon
Petal Surgical wins $10m funding for incisionless surgical robotic tech
Petal Surgical emerged from stealth with nearly $20 million in funding, including a $10 million Series A. Funds support the company’s new approach to surgery that uses acoustic liquefaction (a form of histotripsy), AI and robotics.
Investors included co-leaders K 50 Ventures and TSVC. Meanwhile, Draper’s, ShangBay Capital, Eliot Horowitz and Dr. Fred Moll – considered the “father of surgical robotics,” also participated.
Founder and CEO Prash Chopra
Ampa raises $8.5m to begin US neuromodulation system launch
With this funding the company initiated the US rollout of its transcranial magnetic stimulation system for treating major depressive disorder. The round brings the company’s total funding to $18m.
The Pre-A funding round was led by Nexus NeuroTech Ventures, with participation from other VCs, including Satori Capital and Morningside Ventures, as well as Ampa’s existing investors, which include individual entrepreneurs.
CEO Don Vaughn
VitVio raises $8M for AI-powered OR digitization tech
Returning investor Bek Ventures led the oversubscribed round. Early backers LDV Capital and Tiny Supercomputer Investment Company joined in as well. New investors included Balnord, Thornapple River Capital, healthcare thought leader Joe Mullings and Mati Staniszewski, founder of the voice AI unicorn ElevenLabs.
The round brings its total funding to $10 million. It plans to use funds to expand across U.S. hospitals. The investment can help grow its team across engineering, operations and other key areas.
Co-founder and CEO Thomas Knox
BURL Concepts closes current oversubscribed $4.5 million investment
This oversubscribed total investment of $4.5 million was led by James Brailean, serial tech entrepreneur and managing partner at Karmel Capital, with participation from Acquipharma, Ltd. and K&K Vision GmbH. The recent funding now completes a total investment of $28 million.
The company will use this current investment to launch its CE-marked SONAS ultrasound emboli detection system, final FDA regulatory submissions, clinical experience, and initial commercialization activities in Europe, South Africa, and the U.S.
CEO Peter van der Sluis
FeelTect raises €1.5m in funding round to commercialise wound-care technology
The funding, which will help facilitate a wider launch, came through Irrus Investments, the Western Development Commission, and a network of angel investors.
The money in the latest round will also help support the commercial roll-out of the device, as well as regulatory expansion and help the company expand its team.
Co-Founder Darren Burke
Dexterous Endoscopes wins Venture Kick Stage 1
The company received CHF 10,000 in support from Venture Kick Stage 1 – one of Switzerland’s leading startup programs designed to help early-stage companies validate their business case, engage with potential customers, and prepare for investment.
This milestone will help the company validate the clinical and commercial potential of its variable-stiffness endoscopes for ENT surgery, strengthen its business strategy, and build the foundations for the next stages of Venture Kick.
CEO Yegor Piskarev
